ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Samsung Bioepis, Biogen Announce FDA Filing Acceptance of Lucentis Biosimilar
December 04, 2020Samsung Bioepis and Biogen announced the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for SB11, a proposed biosimilar referencing Lucentis® (ranibizumab). -
Allergan, Molecular Partners’ AMD drug non-inferior to Lucentis
July 23, 2018Allergan, Molecular Partners’ abicipar has shown non-inferiority to Novartis’ Lucentis but with fewer injections in late-stage trials involving patients with neovascular age-related macular degeneration.
Pharma Sources Insight January 2025
